Internal Med

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Saylor BP – The researchers recommend routine questioning of patients with aspects of CMDs regarding urologic symptoms such as intermittency, incomplete emptying, nocturia, and bother. They further recommend first–line medications such as alpha–blockers and phosphodiesterase type–5 inhibitors for managing voiding and sexual dysfunction symptoms in patients who have CMD and urologic disorders.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address